/C O R R E C T I O N -- Decoy Therapeutics, Inc/

Summary

Decoy Therapeutics issued a correction to a prior news release regarding its pan-filovirus program utilizing the FDA Animal Rule pathway and non-dilutive funding. The article does not provide details on the specific corrected information.